Advanced Cell Technology touts positive trial results of stem cell therapy

04/26/2010 | Mass High Tech (Boston)

Advanced Cell Technology reported that its Stargardt's macular dystrophy treatment, which uses retinal pigment epithelium cells, did not cause any side effects in animal subjects. The biotech firm plans to launch human trials of the stem cell therapy in Oregon, New Jersey and Massachusetts.

View Full Article in:

Mass High Tech (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health